Life Science Case Examples Using the Quick Screen Tool for Opportunity Assessments
DOI:
https://doi.org/10.33423/ajm.v24i3.7275Keywords:
management, biopharma, biotechnology, business analysis, business development, risk management, quick screen, heuristicsAbstract
Innovations are plentiful in the biopharma landscape but often fail to reach commercialization. This paper addresses the research question: How can a tool efficiently assess life science opportunities to go to market successfully? This paper analyzes three case studies using the quick screen tool, culminating in a scorecard that reflects commercial potential and readiness. COASTAR’s score of 1.95 represents strong potential despite lacking clinical validation, while JD Bioscience’s score of 2.87 reflects unique attributes and developmental risks. Reviva’s score of 3.08 highlights strong intellectual property and competitive challenges. The quick screen tool simplifies decision-making, with simple rules enhancing heuristic strategies.
References
Boni, A. (2012). Project, product, or company. Journal of Commercial Biotechnology, 18(2).
Boni, A.A. (2019). Evolution of the screening metaphor: Project, product, or platform? Journal of Commercial Biotechnology, 24(4).
Bristol Myers Squibb. (2023, December). Bristol Myers Squibb strengthens its neuroscience portfolio with the acquisition of Karuna Therapeutics. Retrieved from https://news.bms.com/news/corporate-financial/2023/Bristol-Myers-Squibb-Strengthens-Neuroscience-Portfolio-with-Acquisition-of-Karuna-Therapeutics/default.aspx
COASTAR Therapeutics. (2024, March). Technology – COASTAR Therapeutics. Retrieved from https://coastartherapeutics.com/technology/
Eisenhardt, K., & Sull, D.S. (2016). Simple rules: How to thrive in a complex world. New York, New York: Harper Business.
Eisenhardt, K.M. (2021). What is the Eisenhardt method, really? Strategic Organization, 19(1).
FierceBiotech. (2023, August). Prospective NASH market flips to overcrowded as Big Pharma GLP-1s cast a shadow over biotech breakthroughs. Retrieved from https://www.fiercebiotech.com/biotech/prospective-nash-market-flips-failure-over-crowded-big-pharma-glp-1s-cast-shadow-over
Gioia, D. (2021). A systematic methodology for doing qualitative research. The Journal of Applied Behavioral Science, 57(1).
Kruse, S., Bendig, D., & Brettel, M. (2023, September). The potency of shortcuts in decision-making. MIT Sloan Management Review.
Langley, A., & Stensaker, I. (2012). Longitudinal research and analysis. In G. Symon, & C. Cassell (Eds.), Organizational research core methods and current challenges (pp. 149–167). London.
PricewaterhouseCoopers. (2024, January). PwC’s 27th annual CEO survey: US version. Retrieved from https://www.pwc.com/us/en/library/ceo-survey.html
Rashid, Y., Rashid, A., Warraich, M.A., Sabir, S.S., & Waseem, A. (2019). Case study method: A step-by-step guide for business researchers. International Journal of Qualitative Methods, 18. doi:10.1177/1609406919862424
ResearchAndMarkets.com. (2024, January). The schizophrenia drugs market is forecasted at $9.46 billion by 2030, driven by the rising focus on injectable treatments and second-generation therapeutics. Retrieved from https://finance.yahoo.com/news/schizophrenia-drugs-market-forecasted-9-144200166.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAAE5eFPCLtl6SekmNwdvDJyHy_ZFxV1Wuf7ub7uB-jJqQeCNvliVplH5-9OkU51JJxXNk7Q6Pxi5EyUh4NG-gx5g4iTtbASg4hxvOe5d3pbxkmwemywAlioKnBWMC-hG-x5Zxso6SLIcgGZoXLUKwt76vGPcHLiJeBbOcgZ8C4V42
Reviva Pharmaceuticals. (2024, April). PitchBook Data. Retrieved from https://my.pitchbook.com/profile/56394-28/company/profile#recent-notes
Spinelli, S., & Adams, R. (2016). New venture creation: Entrepreneurship for the 21st century (10th Ed.). McGraw-Hill/Irwin.
York, J.M., Abremski, D., Aboujaoude, E., Muthirulan, A., Lipka, E., Patel, K., . . . Luo, P. (2022). The quick screen in action: Project, product, or platform case examples. Journal of Commercial Biotechnology, 27(4).
York, J.M., Pradhan, V., Luo, P., & Toscani, M. (2022). Market selection for MyoTecSci: How to decide “where to play” from multiple options. Journal of Commercial Biotechnology, 27(1).
